
Elagox200 mg
Nuvista Pharma Ltd.
Elagolix Sodium is a gonadotropin-releasing hormone (GnRH) receptor antagonist that is FDA-approved for the following use: Moderate to severe pain associated with endometriosis in women of…
Elagolix Sodium is a gonadotropin-releasing hormone (GnRH) receptor antagonist that is FDA-approved for the following use:
Elagolix Sodium is not indicated for use in postmenopausal women, in men, or in children. It is not a contraceptive and does not treat infertility. Use for indications outside the approved label is not supported by adequate evidence and is not recommended.
| Indication | Dose | Maximum Duration |
|---|---|---|
| Endometriosis pain (standard) | 150 mg orally once daily | Up to 24 months |
| Endometriosis pain (more severe symptoms) | 200 mg orally twice daily | Up to 6 months |
| Moderate hepatic impairment | 150 mg orally once daily | Up to 6 months |
Common side effects of Elagolix Sodium include:
Patients should promptly report severe mood changes, suicidal thoughts, yellowing of skin/eyes, or signs of an allergic reaction while taking Elagolix Sodium.
Elagolix Sodium is contraindicated in the following situations:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.